A highly sensitive assay of platelet factor 3 using a chromogenic substrate

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

A highly sensitive assay of platelet factor 3 using a chromogenic substrate

Abstract

References

Studies on liberation of beta-thromboglobulin from human platelets in vitro

The release of a human platelet specific protein measured by a radioimmunoassay

A radioimmunoassay for platelet factor 4

Platelet aggregation and the availability of platelet factor 3

The nature and significance of platelet products in human plasma

Assay of plasma antihaemophilic globulin (AHG)

The specific assay of Prower-Stuart factor and factor VII

Citations

Determination of platelet factor 3 in whole blood by a chromogenic peptide substrate assay

Differentiation of factor V-like coagulant activity from catalytic phospholipid-like surface activity in membrane fractions derived from human platelets

Platelet factor 3 in plasma fractions: its relation to microparticle size and thromboses

Platelet microparticles: a wide-angle perspective

A study on the efficacy of a phospholipid solution in dogs with aspirin-induced thrombocytopathy

Comparison of the abilities of synthetic and platelet-derived membranes to enhance thrombin formation

Binding of native and thrombin activated factor VIII to platelets

Analysis of platelet factor 3 in platelet concentrates stored for transfusion

Determination of platelet factor 3 by thrombin generation using a micro-coagulation assay

Primary thrombocythemia in a patient with cerebellar infarction

Synthetic substrate assays of the coagulation enzymes and their inhibitors. Comparison with clotting and immunologic methods for clinical and experimental usage

Synthetic peptide substrates in hemostatic testing

The effect of intranasal DDAVP on coagulation and fibrinolytic activity in normal persons

Effect of phospholipid on factor VIII coagulant activity and coagulant antigen

Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation

Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3

Affinity chromatography of coagulation factors II, VIII, IX and X on matrix-bound phospholipid vesicles

The inhibition of clotting complexes of the extrinsic coagulation cascade by the phospholipase A2 isoenzymes from Naja nigricollis venom

HLA-DR is a procoagulant

Screening for congenital coagulation disorders

Related Concepts

Related Feeds

Blood Clotting Disorders

Related Papers

The platelet membrane as a catalytic surface in thrombin generation: availability of platelet factor 1 and platelet factor 3

Effect of red blood cells from patients with sickle cell disease on platelet factor 3 release

Molecular changes during prothrombin activation

Assay of platelet factor 4(PF4) using synthetic thrombin substrates

Stroma free human platelet lysates potentiate the in vivo thrombogenicity of factor Xa by the provision of coagulant-active phospholipid